Peter Goss Discusses FDA Approval of New Implant for Opioid Addiction Treatment

Peter J. Goss was interviewed by Law360 for an article analyzing the FDA’s recent approval of an implantable version of an opioid addiction drug, Probuphine.  (“FDA’s Opioid Implant Nod Shows Pressure To Curb Addiction,” available to Law360 subscribers here.)  Goss noted that the FDA has been under pressure to curb the opioid abuse epidemic, and that the approval […]